Gregory A. Gould

Filings by Gregory A. Gould span 5 companies, the busiest being Seracare Life Sciences Inc, CytoDyn Inc. and NewAge, Inc. Over a trading history stretching from 1 July 2009 to 14 August 2026, the count stands at 35 filings.

Purchases make up the whole of the open-market record (2 purchases, €112k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 30 share grants and 1 option exercise. So far in 2026, the count stands at 1 purchase and no sales.

On 18 August 2026 came the latest disclosure, an open-market purchase for €21k in Aclarion, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.